Competitor Analysis & Market Trends for Epilepsy - Pipeline Review

1
Epilepsy - Pipeline Review, H2 2015
Published on 11 November, 2015 Single
User Price 2000 No of Pages 372
The report focuses on global major leading
industry players with information such as company
profiles, product picture and specifications,
sales, market share and contact information.
Whats more, the Epilepsy - Pipeline Review, H2
2015 development trends and marketing channels
are analyzed.
2
Summary Global Markets Directs, Epilepsy -
Pipeline Review, H2 2015, provides an overview
of the Epilepsys therapeutic pipeline. This
report provides comprehensive information on the
therapeutic development for Epilepsy, complete
with comparative analysis at various stages,
therapeutics assessment by drug target, mechanism
of action (MoA), route of administration (RoA)
and molecule type, along with latest updates, and
featured news and press releases. It also reviews
key players involved in the therapeutic
development for Epilepsy and special features on
late-stage and discontinued projects.
3
Global Markets Directs report features
investigational drugs from across globe covering
over 20 therapy areas and nearly 3,000
indications. The report is built using data and
information sourced from Global Markets Directs
proprietary databases, Company/University
websites, SEC filings, investor presentations and
featured press releases from company/university
sites and industry-specific third party sources,
put together by Global Markets Directs
team. Note Certain sections in the report may
be removed or altered based on the availability
and relevance of data for the indicated disease.
Click Here To Check Complete Report
4
Scope - The report provides a snapshot of the
global therapeutic landscape of Epilepsy - The
report reviews key pipeline products under drug
profile section which includes, product
description, MoA and RD brief, licensing and
collaboration details other developmental
activities - The report reviews key players
involved in the therapeutics development for
Epilepsy and enlists all their major and minor
projects - The report summarizes all the dormant
and discontinued pipeline projects
5

• - A review of the Epilepsy products under
  development by companies and universities/research
  institutes based on information derived from
  company and industry-specific sources
• - Pipeline products coverage based on various
  stages of development ranging from
  pre-registration till discovery and undisclosed
  stages
• - A detailed assessment of monotherapy and
  combination therapy pipeline projects
• - Coverage of the Epilepsy pipeline on the basis
  of target, MoA, route of administration and
  molecule type
• - Latest news and deals relating related to
  pipeline products

Download Sample Brochure
6
Reasons to buy - Provides strategically
significant competitor information, analysis, and
insights to formulate effective RD development
strategies - Identify emerging players with
potentially strong product portfolio and create
effective counter-strategies to gain competitive
advantage - Develop strategic initiatives by
understanding the focus areas of leading
companies - Identify and understand important and
diverse types of therapeutics under development
for Epilepsy - Plan mergers and acquisitions
effectively by identifying key players of the
most promising pipeline
7

• - Devise corrective measures for pipeline
  projects by understanding Epilepsy pipeline depth
  and focus of Indication therapeutics
• - Develop and design in-licensing and
  out-licensing strategies by identifying
  prospective partners with the most attractive
  projects to enhance and expand business potential
  and scope
• - Modify the therapeutic portfolio by identifying
  discontinued projects and understanding the
  factors that drove them from pipeline

Make an Inquiry Before Buying
8
Key questions answered in this report  What
will the market size be in 2020 and what will the
growth rate be? What are the key market
trends? What is driving this market? What are
the challenges to market growth? Who are the
key vendors in this market space? What are the
market opportunities and threats faced by the key
vendors? What are the strengths and weaknesses
of the key vendors? You can request one free
hour of our analysts time when you purchase this
market report. Details are provided within the
report.
9
Epilepsy - Pipeline Review, H2 2015
A detailed qualitative analysis of the factors
responsible for driving and restraining growth of
the Epilepsy - Pipeline Review, H2 2015 and
future opportunities are provided in the report.
Contact 1-302-684-6088 sales_at_marketintelreports.c
om www.marketintelreports.com
Click here to order a copy of Epilepsy - Pipeline
Review, H2 2015